TrialCirculation2022

Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.

Mikhail N Kosiborod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.